Tenderwize
Zurück zur Suche

Poland – Medicinal products for the blood and blood-forming organs – ZAKUP KONCENTRATU REKOMBINOWANEGO CZYNNIKA KRZEPNIĘCIA VIII MINIMUM II GENERACJI WRAZ Z DOSTAWĄ DO REGIONALNYCH CENTRÓW KRWIODAWSTWA I KRWIOLECZNICTWA; znak postępowania: ZZP.ZP.411.96.2026

Narodowe Centrum KrwiWarszawa, PolandNot disclosed24 days leftopen
50

Opportunity Score

Confidence: 45%

Complexity: medium

24 days

Deadline

supplies

Contract

Deep Portfolio Analysis

  • Company fit score
  • Missing certificates
  • Eligibility blockers
  • Bid / No-Bid recommendation
Create account for AI analysis

AI Analysis Summary

Moderate opportunity

Open tender for the supply of recombinant coagulation factor VIII concentrate (minimum second generation) for the treatment of hemophilia A patients, delivered to Regional Blood Donation and Treatment Centers (RCKiK) in Poland. The contract is part of the National Program for the Treatment of Hemophilia and Related Bleeding Disorders 2024-2028. The tender consists of two lots with identical CPV codes, with Lot 1 specifying 2,500,000 IU. Estimated value is not disclosed. Submission is electronic by 2026-07-09 11:00 CEST. Polish language required.

Strengths

Documents available

Open procedure

Medium complexity

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

  • Valid marketing authorization for the product in Poland (or EU-wide)
  • Authorization must cover the entire contract period
  • Product must be in Rp or Rpz category (prescription only); if not, must obtain by contract signing

Buyer

Name

Narodowe Centrum Krwi

Location

Warszawa, POL

Buyer profile

Open profile

Identifier

5252378108

Lots (2)

#LOT-0001Część 1: ZAKUP KONCENTRATU REKOMBINOWANEGO CZYNNIKA KRZEPNIĘCIA VIII WRAZ Z DOSTAWĄ DO REGIONALNYCH CENTRÓW KRWIODAWSTWA I KRWIOLECZNICTWA

Supply of recombinant factor VIII concentrate (min. II generation) with administration set. Total quantity: 2,500,000 IU. Delivery to Regional Blood Centers in Poland by 31 July 2026. Funding subject to approval; contract may be cancelled without compensation if funding is not secured.

33621000POL
#LOT-0002

No specific description provided for this lot in the notice; scope presumed similar to Lot 1 (recombinant factor VIII concentrate), but no quantity or delivery details given.

33621000POL

Procurement Details

Publication

09 Jun 2026

Deadline

09 Jul 2026, 09:00

Procedure

open

Contract

supplies

Language

POL

Publication #

398814-2026

Classification

Performance: Poland

Documents (2)